PL2379501T3 - Sposób wytwarzania estrów aktywowanych - Google Patents

Sposób wytwarzania estrów aktywowanych

Info

Publication number
PL2379501T3
PL2379501T3 PL09802171T PL09802171T PL2379501T3 PL 2379501 T3 PL2379501 T3 PL 2379501T3 PL 09802171 T PL09802171 T PL 09802171T PL 09802171 T PL09802171 T PL 09802171T PL 2379501 T3 PL2379501 T3 PL 2379501T3
Authority
PL
Poland
Prior art keywords
activated esters
preparing activated
preparing
esters
activated
Prior art date
Application number
PL09802171T
Other languages
English (en)
Other versions
PL2379501T4 (pl
Inventor
Antony Bigot
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PL2379501T3 publication Critical patent/PL2379501T3/pl
Publication of PL2379501T4 publication Critical patent/PL2379501T4/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • C07D213/71Sulfur atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL09802171T 2008-12-17 2009-12-15 Sposób wytwarzania estrów aktywowanych PL2379501T4 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0807090A FR2939795B1 (fr) 2008-12-17 2008-12-17 Procede de preparation d'esters actives
PCT/FR2009/052528 WO2010076474A1 (fr) 2008-12-17 2009-12-15 Procede de preparation d'esters actives
EP09802171.0A EP2379501B1 (fr) 2008-12-17 2009-12-15 Procede de preparation d'esters actives

Publications (2)

Publication Number Publication Date
PL2379501T3 true PL2379501T3 (pl) 2014-07-31
PL2379501T4 PL2379501T4 (pl) 2014-12-31

Family

ID=40614691

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09802171T PL2379501T4 (pl) 2008-12-17 2009-12-15 Sposób wytwarzania estrów aktywowanych

Country Status (26)

Country Link
US (1) US8314244B2 (pl)
EP (1) EP2379501B1 (pl)
JP (1) JP5467111B2 (pl)
KR (1) KR101645051B1 (pl)
CN (1) CN102292318B (pl)
AU (1) AU2009334689B2 (pl)
BR (1) BRPI0922972B1 (pl)
CA (1) CA2747105C (pl)
CY (1) CY1115035T1 (pl)
DK (1) DK2379501T3 (pl)
ES (1) ES2459918T3 (pl)
FR (1) FR2939795B1 (pl)
HK (1) HK1163664A1 (pl)
HR (1) HRP20140368T1 (pl)
IL (1) IL213525A (pl)
ME (1) ME01827B (pl)
MX (1) MX2011006624A (pl)
MY (1) MY156761A (pl)
PL (1) PL2379501T4 (pl)
PT (1) PT2379501E (pl)
RS (1) RS53267B (pl)
RU (1) RU2506258C2 (pl)
SG (1) SG172179A1 (pl)
SI (1) SI2379501T1 (pl)
SM (1) SMT201400061B (pl)
WO (1) WO2010076474A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2963007B1 (fr) 2010-07-26 2013-04-05 Sanofi Aventis Derives anticancereux, leur preparation et leur application therapeutique
US11352325B2 (en) 2011-09-28 2022-06-07 Waters Technologies Corporation Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals
US10436790B2 (en) 2011-09-28 2019-10-08 Waters Technologies Corporation Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals
EP3748340B1 (en) 2014-10-30 2022-04-06 Waters Technologies Corporation Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same
CN111796039B (zh) 2014-11-13 2023-03-17 沃特世科技公司 快速标记的n-聚糖的液相色谱校准方法
WO2017222954A1 (en) 2016-06-21 2017-12-28 Waters Technologies Corporation Fluorescence tagging of glycans and other biomolecules through reductive amination for enhanced ms signals
WO2017222955A1 (en) 2016-06-21 2017-12-28 Waters Technologies Corporation Methods of electrospray ionization of glycans modified with amphipathic, strongly basic moieties
CN114839302A (zh) 2016-07-01 2022-08-02 沃特世科技公司 使用分子量截留过滤和过滤器上去糖基化从复杂基质快速制备标记的葡基胺的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5710101B2 (pl) * 1972-10-24 1982-02-24
US5872261A (en) 1997-09-18 1999-02-16 Pierce Chemical Company Preparation of sulfo-N- hydroxy succinimide salts with intermediate formation of diester
US5892057A (en) 1997-09-18 1999-04-06 Pierce Chemical Company Preparation of sulfo-N-hydroxysuccinimide salts
JP2002316987A (ja) * 2001-04-20 2002-10-31 Sankyo Co Ltd 2−アルコキシベンゼン誘導体を含有する医薬
AU2003259163B2 (en) * 2002-08-16 2008-07-03 Immunogen, Inc. Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs
WO2006054426A1 (ja) * 2004-10-29 2006-05-26 National University Corporation Toyama University 高蛍光量子収率型疎水性蛍光プローブ、それを用いる生体高分子検出法ならびに生体高分子間相互作用検出法
JP5265194B2 (ja) * 2004-11-09 2013-08-14 チバ ホールディング インコーポレーテッド 重合開始剤としてのn−置換イミド
WO2007008848A2 (en) * 2005-07-07 2007-01-18 Seattle Genetics, Inc. Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus

Also Published As

Publication number Publication date
US8314244B2 (en) 2012-11-20
MX2011006624A (es) 2011-11-04
CN102292318A (zh) 2011-12-21
IL213525A (en) 2014-11-30
CY1115035T1 (el) 2016-12-14
ES2459918T3 (es) 2014-05-12
DK2379501T3 (da) 2014-04-28
WO2010076474A1 (fr) 2010-07-08
EP2379501B1 (fr) 2014-01-22
FR2939795A1 (fr) 2010-06-18
PT2379501E (pt) 2014-05-02
CA2747105A1 (fr) 2010-07-08
HK1163664A1 (en) 2012-09-14
MY156761A (en) 2016-03-31
SI2379501T1 (sl) 2014-05-30
BRPI0922972A8 (pt) 2018-02-06
CA2747105C (fr) 2017-02-28
US20110313168A1 (en) 2011-12-22
JP5467111B2 (ja) 2014-04-09
KR20110094311A (ko) 2011-08-23
IL213525A0 (en) 2011-07-31
RS53267B (en) 2014-08-29
PL2379501T4 (pl) 2014-12-31
BRPI0922972B1 (pt) 2021-06-01
SG172179A1 (en) 2011-07-28
RU2011129652A (ru) 2013-01-27
SMT201400061B (it) 2014-07-07
JP2012512234A (ja) 2012-05-31
EP2379501A1 (fr) 2011-10-26
HRP20140368T1 (hr) 2014-06-20
ME01827B (me) 2014-12-20
KR101645051B1 (ko) 2016-08-02
AU2009334689A1 (en) 2011-07-07
RU2506258C2 (ru) 2014-02-10
CN102292318B (zh) 2014-01-01
AU2009334689B2 (en) 2015-10-08
BRPI0922972A2 (pt) 2015-08-11
FR2939795B1 (fr) 2010-12-17

Similar Documents

Publication Publication Date Title
ZA201202299B (en) Method for decreasing immunigenicity
HK1132727A1 (en) Process for preparing glycerol esters
PT2096102E (pt) Processo para a produção de metileno-difenil-diisocianatos
PL2252691T3 (pl) Sposób otrzymywania alfa-santalenu
GB0803107D0 (en) Method
EP2309823A4 (en) METHOD OF MANUFACTURING THE DEVICE
GB0810418D0 (en) Method
HK1163664A1 (en) Method for preparing activated esters
EP2357164A4 (en) PROCESS FOR THE PRODUCTION OF A -SUBSTITUTED ESTER
GB0807409D0 (en) Method
EP2374789A4 (en) METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE
GB0807410D0 (en) Method
GB0804981D0 (en) Method
GB0804690D0 (en) Method
EP2298723A4 (en) PRACTICAL PROCEDURE FOR REDUCING ESTERS OR LACTONS
EP2295395A4 (en) PROCESS FOR THE PRODUCTION OF ACETATE OF n-PROPYL
GB0809404D0 (en) Method
IL210051A0 (en) Method for producing aminobiphenylene
EP2357247A4 (en) PROCESS FOR THE PRODUCTION OF POLY-3-HYDROXYALKANOATE
TWI350280B (en) Method for refining glycerin
EP2321435A4 (en) WIEDERAUFKOHLUNGSVERFAHREN
IL211410A0 (en) Method for preparing nebivolol
EP2259269A4 (en) METHOD FOR MANUFACTURING RADIOACTIVE STRONTIUM
GB0805862D0 (en) Method
EP2246322A4 (en) PROCESS FOR PREPARING ALPHA-FLUORO-BETA-AMINO ACIDS